Lead Plaintiff In Endo Investors' Suit Slams Other Bids
A retirement fund leading a proposed class action accusing drugmaker Endo International of artificially inflating its stock price is fighting to remain as the lead plaintiff and urged a Pennsylvania federal...To view the full article, register now.
Already a subscriber? Click here to view full article